Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-06-05
DOI
10.3389/fphar.2015.00116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β
- (2017) Rudy J. Castellani et al. JOURNAL OF ALZHEIMERS DISEASE
- Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β
- (2015) Thomas J. Anastasio Molecular BioSystems
- Link Between Chronic Bacterial Inflammation and Alzheimer Disease
- (2014) Fehmida Bibi et al. CNS & Neurological Disorders-Drug Targets
- A critical analysis of the ‘amyloid cascade hypothesis’
- (2014) Richard A. Armstrong FOLIA NEUROPATHOLOGICA
- Pathways to Alzheimer's disease
- (2014) J. Hardy et al. JOURNAL OF INTERNAL MEDICINE
- Glimepiride reduces CD14 expression and cytokine secretion from macrophages
- (2014) Victoria Ingham et al. Journal of Neuroinflammation
- Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease
- (2014) Cecilia E. Hanzel et al. NEUROBIOLOGY OF AGING
- Bortezomib in combination with thalidomide or lenalidomide or doxorubicin regimens for the treatment of multiple myeloma: a meta-analysis of 14 randomized controlled trials
- (2013) Long Wang et al. LEUKEMIA & LYMPHOMA
- Ruxolitinib: An Oral Janus Kinase 1 and Janus Kinase 2 Inhibitor in the Management of Myelofibrosis
- (2013) Srdan Verstovsek POSTGRADUATE MEDICINE
- Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation
- (2013) Wai T. Wong Frontiers in Cellular Neuroscience
- Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors
- (2012) Anna Yarilina et al. ARTHRITIS AND RHEUMATISM
- Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1
- (2012) J. Fang et al. BLOOD
- Microglia and Inflammation in Alzheimers Disease
- (2012) Shweta Mandrekar-Colucci et al. CNS & Neurological Disorders-Drug Targets
- Low absolute bioavailability of oral naloxone in healthy subjects
- (2012) Kevin Smith et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- (+)-Naloxone, an Opioid-Inactive Toll-Like Receptor 4 Signaling Inhibitor, Reverses Multiple Models of Chronic Neuropathic Pain in Rats
- (2012) Susannah S. Lewis et al. JOURNAL OF PAIN
- The many faces of insulin-like peptide signalling in the brain
- (2012) Ana M. Fernandez et al. NATURE REVIEWS NEUROSCIENCE
- New Proteasome Inhibitors in Myeloma
- (2012) Panisinee Lawasut et al. Current Hematologic Malignancy Reports
- Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs
- (2011) Lei Xie et al. Annual Review of Pharmacology and Toxicology
- Assessing the contribution of inflammation in models of Alzheimer's disease: Figure 1
- (2011) Hannah Johnston et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection
- (2011) Filippo Caraci et al. CELL AND TISSUE RESEARCH
- Physiology of Microglia
- (2011) Helmut Kettenmann et al. PHYSIOLOGICAL REVIEWS
- CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models
- (2010) Sungho Lee et al. AMERICAN JOURNAL OF PATHOLOGY
- Microglial Physiology: Unique Stimuli, Specialized Responses
- (2009) Richard M. Ransohoff et al. Annual Review of Immunology
- Neuroinflammatory changes increase the impact of stressors on neuronal function
- (2009) Alessia Piazza et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-α production via down-regulation of MyD88 expression
- (2009) Abu Shadat M. Noman et al. Innate Immunity
- CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A -Stimulated Microglial Activation
- (2009) E. G. Reed-Geaghan et al. JOURNAL OF NEUROSCIENCE
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)
- (2008) Mark R. Hutchinson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar β amyloid peptide (1-42)-stimulated microglia
- (2008) Ju Hyun Moon et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor γ and nuclear factor-κB in macrophages
- (2008) Brian M. Necela et al. IMMUNOLOGY
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain
- (2007) David J. Loane et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More